The new plant will include a wide range of dosage form capabilities for oral solids, liquids, topicals, films, and manufacturing technologies for granulation, film coating, spray drying, tableting
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
BioFluidica LiquidScan harnesses the power of microfluidics
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
The total cost of the project is estimated at Rs 30 crore
The company plans to expand their capacity to meet the needs of pharma and biotech industries
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
Subscribe To Our Newsletter & Stay Updated
